Schlemm's Canal Basal Lamina: A Variable Resistor?
About the Research Project
Program
Award Type
Standard
Award Amount
$69,850
Active Dates
April 01, 2001 - March 31, 2003
Grant ID
G2001028
Summary
Used aqueous humor leaves the eye through a specially designed filtration tissue known as the trabecular meshwork (TM). The part of this filter with the finest mesh is called the Juxtacanalicular region or simply the JCT. After flowing through the JCT, aqueous humor passes through the cells of the inner wall lining Schlemm’s canal into the venous system. Most clinicians and most researchers believe that the principal site of the resistance to aqueous humor outflow is between the inner aspects of the JCT and the lumen of Schlemm’s canal. Dr. Gong is focusing on the possible role of the basement membrane of Schlemm’s canal in fluid outflow resistance. The basement membrane of Schlemm’s canal exhibits focal discontinuities. She has hypothesized that the normal flow of fluid might “dissolve” little holes in the basement membrane, because the basement membrane becomes more discontinuous in normal eyes when the flow pressure is increased. She is now investigating whether these changes fail to occur in glaucomatous eyes. If this is the case, a new cause for increased flow resistance will have been identified, setting the stage for additional studies to understand the molecular basis for increased resistance.
Related Grants
National Glaucoma Research
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
National Glaucoma Research
Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Nazlee Zebardast, MD, MPH
Current Organization
Massachusetts Eye and Ear Infirmary
Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Nazlee Zebardast, MD, MPH
Current Organization
Massachusetts Eye and Ear Infirmary
National Glaucoma Research
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute